This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 55
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single oral dose of CC-220 and to explore the effect of food on the bioavailability of CC-220 in healthy subjects

Provided treatments

  • Drug: CC-220 0.03 mg
  • Drug: CC-220 0.1 mg
  • Drug: CC-220 0.3 mg
  • Drug: CC-220 1 mg
  • Drug: CC-220 2 mg
  • Drug: Placebo
  • Drug: CC-220
  • Drug: CC-220
  • Drug: CC-220

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01733875. The sponsor of the trial is Celgene and it is looking for 65 volunteers for the current phase.
Official trial title:
A Phase 1, Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of CC-220 and to Explore the Effect of Food on the Bioavailability of CC-220 in Healthy Subjects